Off-label promotion under scrutiny by DOJ

被引：0
|
作者：
Spivack, Peter S.
机构：
来源：
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS | 2008年 / 28卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：10 / 12
页数：3
相关论文
共 50 条
  • [1] Off-label promotion
    Kuehn, BM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06): : 673 - 673
  • [2] Off-label drug promotion
    不详
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
  • [3] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [4] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    [J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [5] OFF-LABEL USE OF MEDICINES UNDER SCRUTINY: BETWEEN COMPETITION LAW AND PHARMA REGULATIONS
    Svetlicinii, Alexandr
    [J]. MEDICINE AND LAW, 2019, 38 (02): : 165 - 181
  • [6] Origins of the Prohibition Against Off-Label Promotion
    Coleman, Terry S.
    [J]. FOOD AND DRUG LAW JOURNAL, 2014, 69 (02) : 161 - 236
  • [7] What Is "False or Misleading" Off-Label Promotion?
    Bi, Kathryn
    [J]. UNIVERSITY OF CHICAGO LAW REVIEW, 2015, 82 (02): : 975 - 1021
  • [8] Off-Label Drug Promotion and the Use of Disclaimers
    McKenney, Dina
    [J]. TEXAS LAW REVIEW, 2013, 92 (01) : 231 - 252
  • [9] Promotion of off-label use not always a crime
    Thompson, Cheryl A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (06) : 478 - +
  • [10] Regulating Off-Label Promotion - A Critical Test
    Robertson, Christopher
    Kesselheim, Aaron S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24): : 2313 - 2315
12345